Actavis now has approximately 900 marketed or registered generic products in the UK, including high-value, technically demanding formulations as well as specialized and niche products that are in high-demand across the UK health system. The combination also expands our industry leading generics pipeline, adding approximately 40 products in development to continue to grow our portfolio of affordable medicines in the UK.